The effects of isoproterenol and propranolol on cytokine profile secretion by cultured tumor-infiltrating lymphocytes derived from colorectal cancer patients

Cell Journal

Volumn 13, Issue 4, 2012, Pages 281-289

  Seyedi, Shahram ^a   Andalib, Alireza ^a   Rezaei, Abbas ^a   Hosseini, Seyed Mohsen ^b   Mohebbi, Seyed Reza ^c   Zali, Mohammad Reza ^c   Vafai, Mohamad ^d   Behboo, Roubik ^d   Tabatabaei, Seyed Abbas ^a   Shahabi, Shahram ^e  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Iranian Scientific Society of Osteoma Care   (Iran)

^e URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beta 2 adrenergic receptor ( 2AR); Colorectal cancer; Isoproterenol; Propranolol; Tumor infiltrating lymphocytes

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 7; ISOPRENALINE; NORADRENALIN; PHYTOHEMAGGLUTININ; PROPRANOLOL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER PATIENT; CD4+ T LYMPHOCYTE; CELL CULTURE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STUDENT T TEST; TH2 CELL; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84858658744     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90.
2. Csiszar A, Szentes T, Haraszti B, Balazs A, Petranyi GG, Pocsik E. The pattern of cytokine gene expression in human colorectal carcinoma. Pathol Oncol Res. 2004; 10(2): 109-116. (Pubitemid 38915604)
3. Koch M, Beckhove P, Op den Winkel J, Autenrieth D, Wagner P, Nummer D. Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Ann Surg. 2006; 244(6): 986-992.
4. Evans C, Dalgleish AG, Kumar D. Review article: immune suppression and colorectal cancer. Aliment Pharmacol Ther. 2006; 24(8): 1163-1677.
5. Romagnani S. The Th1/Th2 paradigm. Immunol Today. 1997. 18(6): 263-266. (Pubitemid 27261442)
6. Wilke CM, Kryczek I, Wei S, Zhao E, Wu K, Wang G. Th17 Cells in Cancer: Help or Hindrance? Carcinogenesis. 2011; 32(5): 643-649.
7. Ji Y, Zhang W. Th17 cells: positive or negative role in tumor? Cancer Immunol Immunother. 2010; 59(7): 979-987.
8. Galon J. Intratumoral Immune Reaction: A Novel Paradigm for Cancer. Cell Journal(Yakhteh). 2011; 13 suppl 2: I5.
9. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000; 52(4): 595-638.
10. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007; 21(6): 736-745. (Pubitemid 47002215)
11. Kim BJ, Jones HP. Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells. Brain Behav Immun. 2010; 24(7): 1126-1136.
12. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol. 1997; 158(9): 4200-4210. (Pubitemid 127483920)
13. Kin NW, Sanders VM. It takes nerve to tell T and B cells what to do. J Leukoc Biol. 2006. 79(6): 1093-1104. (Pubitemid 44835542)
14. Ignatowski TA, Gallant S, Spengler RN. Temporal regulation by adrenergic receptor stimulation of macrophage (M phi)-derived tumor necrosis factor (TNF) production post-LPS challenge. J Neuroimmunol. 1996; 65(2): 107-117.
15. Van der Poll T, Lowry SF. Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol. 1997; 273(6 Pt 2): R1885-890.
16. Dragos D, Tanasescu MD. The effect of stress on the defense systems. J Med Life. 2010; 3(1): 10-18.
17. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res. 2011; 71(4): 1263-1271.
18. Musha H, Ohtani H, Mizoi T, Kinouchi M, Nakayama T, Shiiba K. Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma. Int J Cancer. 2005; 116(6): 949-956. (Pubitemid 41209203)
19. Heriot AG, Marriott JB, Cookson S, Kumar D, Dalgleish AG. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection. Br J Cancer. 2000; 82(5): 1009-1012. (Pubitemid 30128851)
20. Cui G, Goll R, Olsen T, Steigen SE, Husebekk A, Vonen B. Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum. Cancer Immunol Immunother. 2007; 56(7): 985-995. (Pubitemid 46675303)
21. Salama P, Platell C. Host response to colorectal cancer. ANZ J Surg. 2008; 78(9): 745-753.
22. Entringer S, Kumsta R, Nelson EL, Hellhammer DH, Wadhwa PD, Wust S. Influence of prenatal psychosocial stress on cytokine production in adult women. Dev Psychobiol. 2008; 50(6): 579-587.
23. Munemoto Y, Iida Y, Abe J, Saito H, Fujisawa K, Kasahara Y. Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Association between host or tumor factors and survival. Int J Oncol. 2002; 20(2): 403-411.
24. Agarwal SK, Marshall GD, Jr. Beta-adrenergic modulation of human type-1/type-2 cytokine balance. J Allergy Clin Immunol. 2000; 105(1 Pt 1): 91-98. (Pubitemid 30059108)
25. Ramer-Quinn DS, Baker RA, Sanders VM. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol. 1997; 159(10): 4857-4867. (Pubitemid 127471022)
26. Ramer-Quinn DS, Swanson MA, Lee WT, Sanders VM. Cytokine production by naive and primary effector CD4+ T cells exposed to norepinephrine. Brain Behav Immun. 2000; 14(4): 239-255.
27. Wagner P, Koch M, Nummer D, Palm S, Galindo L, Autenrieth D. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer. Ann Surg Oncol. 2008; 15(8): 2310-2317.
28. Liu Y, Yuan Y, Li Y, Zhang J, Xiao G, Vodovotz Y. Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock. J Immunol. 2009; 182(1): 572-580.
29. de Jong E, Suddason T, Lord GM. Translational mini-review series on Th17 cells: development of mouse and human T helper 17 cells. Clin Exp Immunol. 2010; 159(2): 148-158.
30. Straub RH, Rauch L, Rauh L, Pongratz G. Sympathetic inhibition of IL-6, IFN-γ, and KC/CXCL1 and sympathetic stimulation of TGF-beta in spleen of early arthritic mice. Brain Behav Immun. 2011; 25(8): 1708-1715.
31. Friedman GD, Udaltsova N, Habel LA. Norepinephrine antagonists and cancer risk. Int J Cancer. 2011; 128(3): 737-738.
32. st Annual Meeting; 2011 Apr 28-30; Boston, Massachusetts: Black Academic Surgeons; 2011.
33. Fitzgerald PJ. Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer. Clin Epidemiol. 2010; 2:1-3.
34. Young R, Glennon RA. S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats. Psychopharmacology (Berl). 2009; 203(2): 369-382.
35. Bankston JR, Kass RS. Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3. J Mol Cell Cardiol. 2010; 48(1): 246-253.
36. Link A, Selejan S, Maack C, Lenz M, Bohm M. Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock. Crit Care. 2008; 12(6): R159.
37. Mausbach BT, Aschbacher K, Mills PJ, Roepke SK, von Kanel R, Patterson TL. A 5-year longitudinal study of the relationships between stress, coping, and immune cell beta(2)-adrenergic receptor sensitivity. Psychiatry Res. 2008; 160(3): 247-255.